AACR: Identification of Differential Plasma Protein Isoforms in Early Lung Cancer

March 11th, 2021 by

From AACR 2021, this poster demonstrates that measurements at the peptide level for the plasma proteome enable quantification of differential isoform abundance patterns using the Proteograph Product Suite. Read More

AACR: Plasma protein-protein interactome (PPI) maps for non-small cell lung cancer (NSCLC) using the Proteograph Product Suite

April 22nd, 2020 by

This AACR 2020 poster demonstrates how the Proteograph platform can be used to identify PPI clusters that are differentiated between NSCLC and control individuals. Read More

AACR: Analytical validation of the Proteograph platform for rapid and deep proteomic profiling

April 20th, 2020 by

This AACR 2020 poster demonstrates how Seer's proprietary nanoparticle technology can be optimized for unbiased, deep plasma proteome profiling. Read More

AACR: Scalable plasma proteomics in early-stage non-small cell lung cancer

April 10th, 2020 by

This AACR 2020 poster demonstrates the utility of the Proteograph platform to deeply profile plasma proteins as novel biomarkers in healthy vs. early NSCLC Read More